Molecule intelOpportunity: ModerateEssential

Bromocriptine

8 brands · 7 companies · product forms

ATC: G02CB01, N04BC01

Opportunity snapshot

Launch attractiveness
39
Market saturation
18
Price room
52
Regulatory risk
0
8
brands
7
companies
Rs 730.09
median price
3
price points
3.09x
price spread
100
confidence %

Who competes here

Top companies by brand count · leader share 25%

Price room

Across observed sources and strengths
CheapestRs 236
MedianRs 730.09
Most expensiveRs 730.09
Spread3.09×
Sources: DRAP-official, DVAGO, Servaid

max/min price ratio 3.09x across 3 trusted points (Rs 236.0-730.09). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 1 live product for Bromocriptine — each links to its own medicine page.

Why this score

Launch attractiveness

40% supply-gap(25) + 25% price-variation(52) + 20% low-competition(82) + 15% supply-disruption(0), damped by confidence(100). Higher = more attractive, less crowded opportunity.

Market saturation

7 canonical companies and 8 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 3.09x across 3 trusted points (Rs 236.0-730.09). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

No DRAP alerts on this molecule's brands.

Confidence

Full coverage.

Packaged brief for this moderate opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.